ArticleBiologics : targets & therapy2026
Bovine Milk Exosomes as Natural Cytoprotective Nanoplatforms Against Lead-Induced Toxicity.
Article in Biologics : targets & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Exosomes derived from mammalian milk are extracellular vesicular dietary agents capable of interspecies communication. Bovine milk exosomes (BMEs) are abundant natural nanovesicular resources that are enriched in bioactive components, including proteins, lipids, and microRNAs, and as such possess tremendous potential to affect cellular functions in the consumers. Although the applications of BMEs as delivery platforms for exogenous therapeutics are well known, their endogenous therapeutic potential remains relatively undiscerned. This study aimed to examine the cytoprotective role of BMEs as stand-alone therapeutic agents on human embryonic kidney (HEK293T) cells exposed to a prevalent environmental toxicant, lead (Pb). Methods: Isolation of BMEs was performed using standardized ultracentrifugation-based protocols. The physico-biochemical characterization of BMEs was performed using electron microscopy, Western blotting and dynamic light scattering (DLS). The ameliorative effects of BMEs were evaluated using spectrophotometric assays for cellular viability/toxicity and oxidative stress. Results: Our results confirmed that Pb is a potent cytotoxic chemical, the exposure of which was associated with significant decreases in cellular viabilities in MTT reduction and lactate dehydrogenase (LDH) release assays. Additionally, Pb treatment increased the formation of reactive oxygen (ROS) and nitrogen (RNS) species. However, cotreatment with BMEs significantly mitigated Pb-induced oxidative stress and cellular damage. Conclusion: This study highlights the endogenous potential of BMEs as therapeutic and biotechnological agents against chemical toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.